These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
225 related articles for article (PubMed ID: 17951222)
1. Lysophosphatidylcholine as a death effector in the lipoapoptosis of hepatocytes. Han MS; Park SY; Shinzawa K; Kim S; Chung KW; Lee JH; Kwon CH; Lee KW; Lee JH; Park CK; Chung WJ; Hwang JS; Yan JJ; Song DK; Tsujimoto Y; Lee MS J Lipid Res; 2008 Jan; 49(1):84-97. PubMed ID: 17951222 [TBL] [Abstract][Full Text] [Related]
2. Lysophosphatidylcholine as an effector of fatty acid-induced insulin resistance. Han MS; Lim YM; Quan W; Kim JR; Chung KW; Kang M; Kim S; Park SY; Han JS; Park SY; Cheon HG; Dal Rhee S; Park TS; Lee MS J Lipid Res; 2011 Jun; 52(6):1234-1246. PubMed ID: 21447485 [TBL] [Abstract][Full Text] [Related]
4. [Metformin prevents non-alcoholic fatty liver disease in rats: role of phospholipase A2/lysophosphatidylcholine lipoapoptosis pathway in hepatocytes]. Huang Y; Fu JF; Shi HB; Liu LR Zhonghua Er Ke Za Zhi; 2011 Feb; 49(2):139-45. PubMed ID: 21426695 [TBL] [Abstract][Full Text] [Related]
13. Palmitate activation by fatty acid transport protein 4 as a model system for hepatocellular apoptosis and steatosis. Seeßle J; Liebisch G; Schmitz G; Stremmel W; Chamulitrat W Biochim Biophys Acta; 2015 May; 1851(5):549-65. PubMed ID: 25603556 [TBL] [Abstract][Full Text] [Related]
14. Reduction of oxidative stress attenuates lipoapoptosis exacerbated by hypoxia in human hepatocytes. Hwang SY; Yu SJ; Lee JH; Kim HY; Kim YJ Int J Mol Sci; 2015 Feb; 16(2):3323-34. PubMed ID: 25654228 [TBL] [Abstract][Full Text] [Related]
15. Oleic acid protects saturated fatty acid mediated lipotoxicity in hepatocytes and rat of non-alcoholic steatohepatitis. Chen X; Li L; Liu X; Luo R; Liao G; Li L; Liu J; Cheng J; Lu Y; Chen Y Life Sci; 2018 Jun; 203():291-304. PubMed ID: 29709653 [TBL] [Abstract][Full Text] [Related]
16. Caspase-independent hepatocyte death: A result of the decrease of lysophosphatidylcholine acyltransferase 3 in non-alcoholic steatohepatitis. Kakisaka K; Suzuki Y; Fujiwara Y; Suzuki A; Kanazawa J; Takikawa Y J Gastroenterol Hepatol; 2019 Jul; 34(7):1256-1262. PubMed ID: 30160786 [TBL] [Abstract][Full Text] [Related]
17. [Effect of calcium-independent phospholipase A(2) inhibitor in reducing hepatocyte lipoapoptosis and improving insulin resistance]. Shi HB; Fu JF; Huang Y; Liu LR Zhonghua Gan Zang Bing Za Zhi; 2017 Jan; 25(1):27-31. PubMed ID: 28297775 [No Abstract] [Full Text] [Related]
18. A unifying mathematical model of lipid droplet metabolism reveals key molecular players in the development of hepatic steatosis. Wallstab C; Eleftheriadou D; Schulz T; Damm G; Seehofer D; Borlak J; Holzhütter HG; Berndt N FEBS J; 2017 Oct; 284(19):3245-3261. PubMed ID: 28763157 [TBL] [Abstract][Full Text] [Related]
19. Krabbe disease: psychosine-mediated activation of phospholipase A2 in oligodendrocyte cell death. Giri S; Khan M; Rattan R; Singh I; Singh AK J Lipid Res; 2006 Jul; 47(7):1478-92. PubMed ID: 16645197 [TBL] [Abstract][Full Text] [Related]
20. A human hepatocellular in vitro model to investigate steatosis. Gómez-Lechón MJ; Donato MT; Martínez-Romero A; Jiménez N; Castell JV; O'Connor JE Chem Biol Interact; 2007 Jan; 165(2):106-16. PubMed ID: 17188672 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]